Free Trial

Werewolf Therapeutics (HOWL) Short Interest Ratio & Short Volume

$1.84
-0.05 (-2.65%)
(As of 10/9/2024 ET)

Werewolf Therapeutics Short Interest Data

Werewolf Therapeutics (HOWL) has a short interest of 1.12 million shares, representing 3.68% of the float (the number of shares available for trading by the public). This marks a 3.70% increase in short interest from the previous month. The short interest ratio (days to cover) is 3.8, indicating that it would take 3.8 days of the average trading volume of 245,659 shares to cover all short positions.

Current Short Interest
1,120,000 shares
Previous Short Interest
1,080,000 shares
Change Vs. Previous Month
+3.70%
Dollar Volume Sold Short
$2.62 million
Short Interest Ratio
3.8 Days to Cover
Last Record Date
September 15, 2024
Outstanding Shares
43,455,000 shares
Float Size
30,400,000 shares
Short Percent of Float
3.68%
Today's Trading Volume
76,614 shares
Average Trading Volume
245,659 shares
Today's Volume Vs. Average
31%
Short Selling Werewolf Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Werewolf Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

HOWL Short Interest Over Time

HOWL Days to Cover Over Time

HOWL Percentage of Float Shorted Over Time

Werewolf Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
9/15/20241,120,000 shares $2.62 million +3.7%3.7%3.8 $2.34
8/31/20241,080,000 shares $2.33 million +1.9%3.6%3.5 $2.16
8/15/20241,060,000 shares $2.14 million +3.9%3.5%3.3 $2.02
7/31/20241,020,000 shares $2.30 million -2.9%3.4%3.2 $2.25
7/15/20241,050,000 shares $3.00 million +55.1%3.5%3.4 $2.86
6/30/2024677,100 shares $1.65 million +38.8%2.3%2.2 $2.44
6/15/2024487,900 shares $1.47 million +4.0%1.6%2.3 $3.01
5/31/2024469,100 shares $2.43 million +26.1%1.6%2.5 $5.17
5/15/2024372,000 shares $1.80 million -10.3%1.3%2 $4.85
4/30/2024414,500 shares $2.59 million +1.1%1.4%2.2 $6.24
4/15/2024410,100 shares $2.25 million -13.1%1.4%1.7 $5.49
3/31/2024472,000 shares $3.06 million +9.3%1.6%2 $6.48
3/15/2024432,000 shares $2.65 million -7.1%1.6%1.7 $6.14
2/29/2024464,800 shares $3.22 million +5.0%1.7%1.7 $6.92
2/15/2024442,600 shares $2.79 million +101.9%2.0%1.7 $6.30
1/31/2024219,200 shares $1.01 million -11.8%1.0%0.8 $4.63
1/15/2024248,600 shares $1.25 million -13.2%1.1%0.3 $5.04
12/31/2023286,500 shares $1.11 million -4.6%N/A0.3 $3.86
12/15/2023300,200 shares $897,598.00 -27.0%1.3%0.3 $2.99
11/30/2023411,400 shares $1.01 million -20.7%1.8%0.5 $2.45
11/15/2023518,500 shares $1.14 million +62.9%2.3%0.6 $2.20
10/31/2023318,400 shares $796,000.00 +562.0%1.4%0.4 $2.50
10/15/202348,100 shares $111,111.00 +14.3%0.2%1.5 $2.31
9/30/202342,100 shares $90,094.00 +10.8%0.2%1.2 $2.14
9/15/202338,000 shares $97,660.00 -5.0%0.2%1 $2.57
8/31/202340,000 shares $109,600.00 -36.1%0.2%1 $2.74
8/15/202362,600 shares $157,126.00 +37.6%0.3%1.4 $2.51
7/31/202345,500 shares $122,395.00 -18.3%0.2%1.1 $2.69
7/15/202355,700 shares $176,012.00 -10.0%0.3%1.4 $3.16
6/30/202361,900 shares $188,795.00 +36.6%0.3%1.6 $3.05
6/15/202345,300 shares $150,849.00 -22.4%0.2%1.1 $3.33
5/31/202358,400 shares $186,296.00 +14.5%0.3%1.4 $3.19
5/15/202351,000 shares $143,310.00 No Change0.2%1 $2.81
10/31/2022153,500 shares $454,360.00 -1.7%1.0%1.6 $2.96
10/15/2022156,200 shares $657,602.00 -15.5%1.0%1.8 $4.21
9/30/2022184,900 shares $833,899.00 +42.7%N/A2.7 $4.51
9/15/2022129,600 shares $789,264.00 -10.3%0.9%0.9 $6.09
8/31/2022144,500 shares $731,170.00 -23.9%1.0%1 $5.06
8/15/2022189,800 shares $1.09 million -28.5%1.4%1.3 $5.74
7/31/2022265,300 shares $1.21 million -15.1%2.0%1.8 $4.56
Bigger Than Nvidia? (Ad)

Bigger Than Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that's all they'll talk about.

Go here now for this breaking story.
7/15/2022312,500 shares $1.47 million -37.7%2.4%1.8 $4.70
6/30/2022501,600 shares $2.05 million -50.8%3.8%1.3 $4.09
6/15/20221,020,000 shares $4.73 million +2.4%7.8%2.6 $4.64
5/31/2022996,100 shares $3.78 million +7.4%7.6%3 $3.79
5/15/2022927,900 shares $4.40 million +1.7%7.1%2.8 $4.74
4/30/2022912,000 shares $4.06 million +19.3%7.0%2.9 $4.45
4/15/2022764,400 shares $3.51 million +76.5%5.8%2.6 $4.59
3/31/2022433,000 shares $1.91 million +6.6%N/A1.5 $4.40
3/15/2022406,200 shares $1.86 million +19.6%3.1%5.5 $4.59
2/28/2022339,600 shares $2.43 million +15.3%2.6%2.8 $7.16
2/15/2022294,500 shares $2.21 million +3.6%2.3%2.4 $7.49
1/31/2022284,200 shares $2.59 million -60.8%2.2%2.3 $9.11
1/15/2022725,100 shares $6.47 million -7.2%N/A0 $8.92
12/31/2021781,700 shares $9.31 million +23.0%6.0%7.4 $11.91
12/15/2021635,300 shares $8.85 million -2.6%4.9%6.6 $13.93
11/30/2021651,900 shares $9.45 million -1.0%N/A14.4 $14.49
11/15/2021658,300 shares $10.52 million -3.2%5.0%26.3 $15.98
10/29/2021680,100 shares $10.66 million +0.0%4.4%32.4 $15.67
10/15/2021680,000 shares $11.61 million +2.5%4.4%34 $17.07
9/30/2021663,300 shares $11.38 million -2.0%4.3%25.5 $17.16
9/15/2021676,600 shares $11.71 million +3.9%4.6%11.3 $17.30
8/31/2021651,400 shares $11.59 million -0.8%4.4%8.7 $17.80
8/13/2021656,400 shares $9.48 million No Change4.4%7 $14.44

HOWL Short Interest - Frequently Asked Questions

What is Werewolf Therapeutics' current short interest?

Short interest is the volume of Werewolf Therapeutics shares that have been sold short but have not yet been closed out or covered. As of September 15th, traders have sold 1,120,000 shares of HOWL short. 3.68% of Werewolf Therapeutics' shares are currently sold short. Learn More on Werewolf Therapeutics' current short interest.

What is a good short interest ratio for Werewolf Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HOWL shares currently have a short interest ratio of 4.0. Learn More on Werewolf Therapeutics's short interest ratio.

What is a good short interest percentage for Werewolf Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.68% of Werewolf Therapeutics' floating shares are currently sold short.

Is Werewolf Therapeutics' short interest increasing or decreasing?

Werewolf Therapeutics saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 1,120,000 shares, an increase of 3.7% from the previous total of 1,080,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Werewolf Therapeutics' float size?

Werewolf Therapeutics currently has issued a total of 43,455,000 shares. Some of Werewolf Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Werewolf Therapeutics currently has a public float of 30,400,000 shares.

How does Werewolf Therapeutics' short interest compare to its competitors?

3.68% of Werewolf Therapeutics' shares are currently sold short. Here is how the short interest of companies compare to Werewolf Therapeutics: Rani Therapeutics Holdings, Inc. (5.32%), Shattuck Labs, Inc. (13.29%), Adicet Bio, Inc. (5.07%), Passage Bio, Inc. (3.65%), Xilio Therapeutics, Inc. (0.06%), Curis, Inc. (2.40%), Biora Therapeutics, Inc. (6.36%), Pyxis Oncology, Inc. (8.07%), Nektar Therapeutics (4.36%), GH Research PLC (4.96%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($6.15 billion), Charter Communications, Inc. ($4.04 billion), Paychex, Inc. ($2.77 billion), Nu Holdings Ltd. ($2.71 billion), Cencora, Inc. ($2.34 billion), Aptiv PLC ($2.18 billion), Tractor Supply ($2.07 billion), International Paper ($2.01 billion), AppLovin Co. ($1.95 billion), and Moderna, Inc. ($1.89 billion). View all of the most shorted stocks.

What does it mean to sell short Werewolf Therapeutics stock?

Short selling HOWL is an investing strategy that aims to generate trading profit from Werewolf Therapeutics as its price is falling. HOWL shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Werewolf Therapeutics?

A short squeeze for Werewolf Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of HOWL, which in turn drives the price of the stock up even further.

How often is Werewolf Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HOWL, twice per month. The most recent reporting period available is September, 15 2024.




This page (NASDAQ:HOWL) was last updated on 10/9/2024 by MarketBeat.com Staff
From Our Partners